Clinical Rheumatology

, Volume 25, Issue 2, pp 159–163 | Cite as

Intra-articular methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis: a clinical and sonographic study

  • Annamaria Iagnocco
  • Angela Cenoni
  • Giulio Coari
  • Alejandra Ossandon
  • Guido Valesini
  • Raffaele Masciangelo
Original Article

Abstract

The aim of our study was to evaluate the effects of intra-articular methotrexate (MTX) in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Twenty-three consecutive patients, 10 with RA and 13 with PsA, with prevalent or unique arthritic involvement of one knee, were treated with intra-articular injections of MTX 10 mg every 7 days for 8 weeks. Before the beginning of the treatment and after 9 and 17 weeks, the patients underwent a clinical evaluation measuring maximal knee flexion angle, visual analog scale (VAS) and erythrocyte sedimentation rate (ESR). On the same days, an ultrasonographic examination of the involved knee was performed by two independent experienced operators. Synovial thickness in the suprapatellar bursa and the presence of joint effusion and Baker’s cyst were assessed. An increase of the mean value of maximal knee flexion angle and a reduction of the mean values of ESR and VAS between TO, T9 and T17 were demonstrated. Ultrasonographic evaluation showed significant reduction of synovial thickness and joint effusion. No differences were detected for the presence of Baker’s cyst. We may conclude that repeated intra-articular injections of MTX resulted in a decrease of local as well as systemic inflammatory signs. As far as we know, this is the first study that explores the effects of intra-articular MTX in RA and PsA both clinically and by ultrasonography.

Keywords

Intra-articular methotrexate Joint sonography Psoriatic arthritis Rheumatoid arthritis 

Abbreviations

ERS

Erythrocyte sedimentation rate

MTX

Methotrexate

PsA

Psoriatic arthritis

RA

Rheumatoid arthritis

US

Ultrasonography

VAS

Visual analog scale

References

  1. 1.
    Canoso J J (1998) Aspiration and injection of joints and periarticular tissues. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London, pp 2.12.1–2.12.12Google Scholar
  2. 2.
    Altman RD, Moskowitz R (1998) Intra-articular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 25:2203–2212PubMedGoogle Scholar
  3. 3.
    Listrat V, Ayral X, Patarnello F et al (1997) Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 5:153–160PubMedCrossRefGoogle Scholar
  4. 4.
    Frizziero L, Govoni E, Bacchini P (1998) Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 16:441–449PubMedGoogle Scholar
  5. 5.
    Songsiridej N, Fürst DE (1990) Methotrexate: the rapidly acting drug. Baillieres Clin Rheumatol 4:575–593PubMedCrossRefGoogle Scholar
  6. 6.
    Segal R, Yaron M, Tartakovsky B (1990) Methotrexate: mechanism of action in rheumatoid arthritis. Semin Arthritis Rheum 20:190–199PubMedCrossRefGoogle Scholar
  7. 7.
    Davis JC, Klippel JH (1999) Antimalarials and immunosuppressive drugs. In: Lahita RG (ed) Systemic lupus erythematosus. Academic Press, San Diego, pp 976–977Google Scholar
  8. 8.
    Seitz M (1999) Molecular and cellular effects of methotrexate. Curr Opin Rheumatol 11:226–232PubMedCrossRefGoogle Scholar
  9. 9.
    Gruber HE, Hoffer ME, McAllister DR et al (1989) Increased adenosine concentration in blood from ischemic myocardium by AICA-riboside: effects on flow, granulocytes and injury. Circulation 80:1400–1411PubMedGoogle Scholar
  10. 10.
    Barankiewicz J, Ranlov G, Jimenez R, Gruber HE (1990) Selective adenosine release from human B but not T lymphoid cell line. J Biol Chem 265:15738–15743PubMedGoogle Scholar
  11. 11.
    Kremer JM (1994) The mechanism of action of methotrexate in rheumatoid arthritis: the search continues. J Rheumatol 21:1–5PubMedGoogle Scholar
  12. 12.
    Genestier L, Paillot R, Fournel S, Ferraro C, Miossec P, Revillard JP (1998) Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest 102:322–328PubMedCrossRefGoogle Scholar
  13. 13.
    Hall GH, Head AC (1975) Intraarticular methotrexate. Lancet 2:409PubMedCrossRefGoogle Scholar
  14. 14.
    Marks JS, Stewart IM, Hunter JA (1976) Intra-articular methotrexate in rheumatoid arthritis. Lancet 2:857–858PubMedCrossRefGoogle Scholar
  15. 15.
    Mussini C, Manzini E, Curci G, Zaniol P, Fiocchi R (1978) Intraarticular use of 4-amino-N10-rnethyl-pteroyl-glutamic acid (methotrexate) for the treatment of rheumatoid synovitis. Chir Organi Mov 64:193–198PubMedGoogle Scholar
  16. 16.
    Alamo M, Grisanti M (1991) Methotrexate in rheumatoid arthritis. Rev Med Chil 119:691–700PubMedGoogle Scholar
  17. 17.
    Hall GH, Jones BJ, Head AC, Jones VE (1978) Intra-articular methotrexate. Clinical and laboratory study in rheumatoid and psoriatic arthritis. Ann Rheum Dis 37:351–356PubMedCrossRefGoogle Scholar
  18. 18.
    Franchi F, Seminara P, Codacci-Pisanelli G, Aronne T, Avella A, Bonomo L (1989) Intra-articular methotrexate in the therapy of rheumatoid arthritis. Recenti Prog Med 80:261–262PubMedGoogle Scholar
  19. 19.
    Iagnocco A, Coari G, Palombi G, Valesini G (2002) Knee joint synovitis in Sjogren’s syndrome. Sonographic study. Scand J Rheumatol 31:291–295CrossRefGoogle Scholar
  20. 20.
    Giovagnorio F, Martinoli C, Coari G (2001) Power Doppler sonography in knee arthritis—a pilot study. Rheumatol Int 20:101–104PubMedCrossRefGoogle Scholar
  21. 21.
    Rubaltelli L, Fiocco U, Cozzi L et al (1994) Prospective sonographic and arthroscopic evaluation of proliferative knee joint synovitis. J Ultrasound Med 13:855–862PubMedGoogle Scholar
  22. 22.
    Henderson B, Hedwards JCW (1987) Structural and microscope changes. In: Henderson B, Hedwards JCW (eds) The synovial lining in health and disease. Chapman & Hall, London, pp 233–237Google Scholar
  23. 23.
    Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:55–78PubMedCrossRefGoogle Scholar
  24. 24.
    Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRefGoogle Scholar
  25. 25.
    Coari G, Iagnocco A, Maggi S et al (1996) Sonographic findings in haemodialysis-related chronic arthropathy. Eur Radiol 6:890–894PubMedCrossRefGoogle Scholar
  26. 26.
    Ostergaard M, Gideon P, Henriksen O, Lorensen I (1994) Synovial volume—a marker of disease severity in rheumatoid arthritis? Quantification by MRI. Scand J Rheumatol 23:197–202PubMedCrossRefGoogle Scholar
  27. 27.
    Hammer M, Mielke H, Wagener P, Schwarzrock R, Giebel G (1986) Sonography and NMR imaging in rheumatoid gonoarthritis. Scand J Rheumatol 15:157–164PubMedCrossRefGoogle Scholar
  28. 28.
    Wyld PJ, Dawson KP, Chisholm RJ (1984) Ultrasound in the assessment of synovial thickening in the hemophilic knee. Aust N Z J Med 14:678–680PubMedGoogle Scholar
  29. 29.
    Van Holsbeeck M, Van Holsbeeck K, Gevers G et al (1988) Staging and follow-up of rheumatoid arthritis of the knee. Comparison of sonography, thermography and clinical assessment. J Ultrasound Med 7:561–566Google Scholar
  30. 30.
    Ostergaard M, Stoltenberg M, Lovgreen-Nielsen P, Volck B, Jensen CH, Lorenzen I (1997) Magnetic resonance imaging-determined synovial membrane and joint effusion volumes in rheumatoid arthritis and osteoarthritis: comparison with the macroscopic and microscopic appearance of the synovium. Arthritis Rheum 40:1856–1867PubMedCrossRefGoogle Scholar
  31. 31.
    Clunie G, Hall-Craggs MA, Paley MN et al (1997) Measurement of synovial lining volume by magnetic resonance imaging of the knee in chronic synovitis. Ann Rheum Dis 56:526–534PubMedCrossRefGoogle Scholar
  32. 32.
    Bird HA, Ring EF, Daniel R, Bacon PA (1977) Comparison of intra-articular methotrexate with intra-articular triamcinolone hexacetonide by thermography. Curr Med Res Opin 5:141–146PubMedGoogle Scholar
  33. 33.
    Foong WC, Green KL (1993) Treatment of antigen-induced arthritis in rabbits with liposome-entrapped methotrexate injected intra-articularly. J Pharm Pharmacol 45:204–209PubMedGoogle Scholar
  34. 34.
    Williams AS, Camilleri JP, Goodfellow RM, Williams BD (1996) A single intra-articular injection liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis. Br J Rheumatol 35:719–724PubMedCrossRefGoogle Scholar
  35. 35.
    Gao IK, Leins C, Bohlen H, Heilig B, Lemmel EM (1988) Inhibition of interleukin-8 synthesis by intraarticular methotrexate therapy in patients with rheumatoid arthritis. Z Rheumatol 57:95–100CrossRefGoogle Scholar
  36. 36.
    Blyth T, Stirling A, Coote J, Land D, Hunter JA (1998) Injection of the rheumatoid knee: does intra-articular methotrexate or rifampicin add to the benefits of triamcinolone hexacetonide? Br J Rheumatol 37:770–772PubMedCrossRefGoogle Scholar
  37. 37.
    Williams AS, Topley N, Dojcinov S, Richards PJ, Williams BD (2001) Amelioration of rat antigen-induced arthritis by liposomally conjugated methotrexate is accompanied by down-regulation of cytokine mRNA expression. Rheumatology 40:375–383PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2006

Authors and Affiliations

  • Annamaria Iagnocco
    • 1
  • Angela Cenoni
    • 1
  • Giulio Coari
    • 1
  • Alejandra Ossandon
    • 1
  • Guido Valesini
    • 1
  • Raffaele Masciangelo
    • 2
  1. 1.Department of Clinical and Applied Medical Therapy, Rheumatology UnitUniversity of Rome “La Sapienza”RomeItaly
  2. 2.Department of Experimental Medicine and PathologyUniversity of Rome “La Sapienza”RomeItaly

Personalised recommendations